首页> 外国专利> CRYSTAL FORM A OF APATINIB MESYLATE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

CRYSTAL FORM A OF APATINIB MESYLATE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

机译:甲磺酸阿帕替尼的晶体形式A,其制备方法及其应用

摘要

The invention discloses a form A of mesylate for nicotinamide derivatives and preparation method and application thereof, wherein the XRPD pattern of the form A of mesylate for nicotinamide derivatives has a diffraction peak at 2¸=5.34, 10.341, 14.438, 15.841, 17.32, 18.301, 18.68, 19.005, 19.577, 20.26, 21.161, 21.859, 22.379, 23.04, 23.5, 24.177, 24.959, 25.881, 26.641, 27.18, 28.3, 28.999, 29.501, 31.96, 32.258, 33.999, 36.798, 37.38 and 41.297 with the error range of the 2¸ values being ±0.2. The form A of mesylate for nicotinamide derivatives provided by the present invention has excellent high-temperature stability, high-humidity stability and illumination stability, and it can be applied to drugs for treating advanced non-small cell lung cancers, gastric cancers, liver cancer or breast cancer. It has preferable bioavailability, and meanwhile the provided qualitative and quantitative information has great significance on further study of the efficacy of such solid drugs.
机译:本发明公开了一种烟酰胺衍生物甲磺酸盐的形式A及其制备方法和应用,其中烟酰胺衍生物甲磺酸盐的形式的XRPD图谱具有在2θ= 5.34、10.341、14.438、15.841、17.32、18.301的衍射峰。 ,18.68、19.005、19.577、20.26、21.161、21.859、22.379、23.04、23.5、24.177、24.959、25.881、26.641、27.18、28.3、28.999、29.501、31.96、32.258、33.999、36.798、37.38和41.297 2¸值中的±为±0.2。本发明提供的烟酰胺类衍生物的甲磺酸盐形式A具有优异的高温稳定性,高湿稳定性和光照稳定性,可用于治疗晚期非小细胞肺癌,胃癌,肝癌的药物。或乳腺癌。它具有较好的生物利用度,同时所提供的定性和定量信息对进一步研究此类固体药物的疗效具有重要意义。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号